BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32179749)

  • 21. HMGN1 modulates estrogen-mediated transcriptional activation through interactions with specific DNA-binding transcription factors.
    Zhu N; Hansen U
    Mol Cell Biol; 2007 Dec; 27(24):8859-73. PubMed ID: 17938209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
    Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
    Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hematopoietic and leukemia stem cells by regulatory T cells.
    Riether C
    Front Immunol; 2022; 13():1049301. PubMed ID: 36405718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells.
    Pan F; Iwasaki M; Wu W; Jiang Y; Yang X; Zhu L; Zhao Z; Cleary ML
    Blood Adv; 2023 Jun; 7(11):2504-2519. PubMed ID: 36705973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3.
    Ming T; Yuting L; Meiling D; Shengtao C; Jihua R; Hui Z; Wanjin C; Dian L; Tingting G; Juan C; Zhenzhen Z
    Antiviral Res; 2024 Jan; 221():105796. PubMed ID: 38181856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.
    Chen Z; Huo D; Li L; Liu Z; Li Z; Xu S; Huang Y; Wu W; Zhou C; Liu Y; Kuang M; Wu F; Li H; Qian P; Song G; Wu X; Chen J; Hou Y
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33755722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells.
    Wesely J; Kotini AG; Izzo F; Luo H; Yuan H; Sun J; Georgomanoli M; Zviran A; Deslauriers AG; Dusaj N; Nimer SD; Leslie C; Landau DA; Kharas MG; Papapetrou EP
    Cell Rep; 2020 Jun; 31(9):107688. PubMed ID: 32492433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of mutations in the cohesin complex in acute myeloid leukemia.
    Mazumdar C; Majeti R
    Int J Hematol; 2017 Jan; 105(1):31-36. PubMed ID: 27796738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of ATM depends on chromatin interactions occurring before induction of DNA damage.
    Kim YC; Gerlitz G; Furusawa T; Catez F; Nussenzweig A; Oh KS; Kraemer KH; Shiloh Y; Bustin M
    Nat Cell Biol; 2009 Jan; 11(1):92-6. PubMed ID: 19079244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain.
    Farley SJ; Grishok A; Zeldich E
    Epigenetics Chromatin; 2022 Dec; 15(1):39. PubMed ID: 36463299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
    Dong F; Bai H; Wang X; Zhang S; Wang Z; Xie M; Zhang S; Wang J; Hao S; Cheng T; Ema H
    Blood Adv; 2019 Feb; 3(3):419-431. PubMed ID: 30733302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
    Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
    Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.
    Fiskus W; Sharma S; Qi J; Valenta JA; Schaub LJ; Shah B; Peth K; Portier BP; Rodriguez M; Devaraj SG; Zhan M; Sheng J; Iyer SP; Bradner JE; Bhalla KN
    Mol Cancer Ther; 2014 May; 13(5):1142-54. PubMed ID: 24435446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
    Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
    Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The accessibility of histone H3 tails in chromatin modulates their acetylation by P300/CBP-associated factor.
    Herrera JE; Schiltz RL; Bustin M
    J Biol Chem; 2000 Apr; 275(17):12994-9. PubMed ID: 10777601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.